Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04337710 · ClinicalTrials.gov registry record · NA
Exclusive Enteral Nutrition in Preterm Neonates
A NA study of Enteral Feeding Intolerance and Premature; Infant, Light-for-dates, sponsored by University of Alabama at Birmingham.
- Active
- Registry status
- NA
- Development phase
- 102
- Enrollment target
- 1
- Study location
NCT04337710: Active NA study of Enteral Feeding Intolerance and Premature; Infant, Light-for-dates, sponsored by University of Alabama at Birmingham.
NCT04337710 is a NA study of Enteral Feeding Intolerance and Premature; Infant, Light-for-dates that is active but no longer recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 102 participants, above the 59-participant average among 3 other Enteral Feeding Intolerance trials with a reported enrollment target (73% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04337710, a NA study of Enteral Feeding Intolerance and Premature; Infant, Light-for-dates, is active but no longer recruiting, sponsored by University of Alabama at Birmingham.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 102 participants
- Enrollment target
- 1
- Study location
Study Summary
To test the hypothesis that early exclusive enteral nutrition with the minimal use of parenteral nutrition will improve preterm infants' nutritional outcomes when compared to delayed progression of enteral nutrition and prolonged use of parenteral nutrition.
Primary Outcome
Days of full feeds in the first 28 days after birth
Conditions Studied
Interventions
- PROCEDURE Exclusive Enteral Nutrition
- PROCEDURE Progressive Enteral Nutrition
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2021-05-27 |
| Est. Completion | 2026-05 |
| Phase | NA |
What the registry record for NCT04337710 still lists
NCT04337710 is an interventional study that assigns participants to a tested intervention. The registered 102 participants enrollment target is mid-sized for trials with a published cap, above the 59-participant average among 3 other Enteral Feeding Intolerance trials with a reported enrollment target (73% higher).
The record links to 2 conditions, with Enteral Feeding Intolerance appearing as the primary indexed condition, and to 2 interventions - of which Exclusive Enteral Nutrition is the first listed.
NCT04337710 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT04337710 about?
NCT04337710 is a clinical study titled "Exclusive Enteral Nutrition in Preterm Neonates". To test the hypothesis that early exclusive enteral nutrition with the minimal use of parenteral nutrition will improve preterm infants' nutritional outcomes when compared to delayed progression of enteral nutrition and prolonged use of parenteral nutrition.
What is the current status of trial NCT04337710?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 102 participants. The study started on 2021-05-27. Estimated completion is 2026-05.
What conditions does trial NCT04337710 study?
This clinical trial studies the following conditions: Enteral Feeding Intolerance, Premature; Infant, Light-for-dates.
What interventions are being tested in trial NCT04337710?
The interventions under investigation include: Exclusive Enteral Nutrition (PROCEDURE), Progressive Enteral Nutrition (PROCEDURE).
Who is sponsoring clinical trial NCT04337710?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04337710 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Enteral Feeding Intolerance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03704662 · 102 participants · NA
Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma
- NCT04174742 · 102 participants
Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer
- NCT04275362 · 102 participants
Gait Analysis of a Lateral-Pivot Design Total Knee Replacement
- NCT04541082 · 102 participants · Phase 1
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI